EDEN ETCHEVERRIA: Open Payments
NPI 1801314315 · FRANKLIN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 67 payments from 14 companies in 2025. Trend: 2023 $1,124 · 2024 $1,395 · 2025 $1,262
Food & beverage: $1,248Education: $13
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $380 |
| Janssen Biotech, Inc. | 8 | $263 |
| ABBVIE INC. | 20 | $146 |
| Lilly USA, LLC | 4 | $107 |
| Incyte Corporation | 4 | $86 |
| Arcutis Biotherapeutics, Inc. | 3 | $71 |
| PFIZER INC. | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Almirall LLC | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, TALTZ, OPZELURA, Zoryve, CIBINQO, Sotyktu.
Industry payments across LA — which companies pay providers there.
